BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37422261)

  • 1. Abdominal Castleman's disease with 18F-FDG PET/CT.
    Badenes Romero Á; Milà López M; Vallansot RO; Achury Murcia CA; Patricia Fierro Alanis M; Carrera Salazar D; Muro VI; Quintero Caicedo LM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):418-419. PubMed ID: 37422261
    [No Abstract]   [Full Text] [Related]  

  • 2. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
    Luo Y; Wang L; Pan Q; Ma Y; Li F
    Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
    Wang Y; Dong A; Yang B; Lu J
    Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
    Robinson H; Prince HM; Ramdave S; Seymour JF; Elliott P; Hicks R
    Leuk Lymphoma; 2006 Dec; 47(12):2664-6. PubMed ID: 17169817
    [No Abstract]   [Full Text] [Related]  

  • 6. PET/CT imaging with 18F-FDG in Castleman disease.
    Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
    [No Abstract]   [Full Text] [Related]  

  • 7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman's disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection.
    Bertagna F; Biasiotto G; Rodella R; Giubbini R; Alavi A
    Jpn J Radiol; 2010 Apr; 28(3):231-4. PubMed ID: 20437136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of primary hepatic myopericytoma and mediastinal Castleman disease in one patient: an interesting 18F-FDG PET/CT imaging case.
    Ma GY; Guan ZW
    Chin Med J (Engl); 2021 Sep; 134(20):2498-2499. PubMed ID: 34561326
    [No Abstract]   [Full Text] [Related]  

  • 9. FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
    Blockmans D; Maes A; Stroobants S; Bobbaers H; Mortelmans L
    Clin Nucl Med; 2001 Nov; 26(11):975-6. PubMed ID: 11595872
    [No Abstract]   [Full Text] [Related]  

  • 10. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
    Fu Z; Liu M; Chen X; Yang X; Li Q
    Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castleman's disease presenting as fever of unknown origin: diagnostic value of fluorodeoxyglucose-positron emission tomography/computed tomography.
    Roca B; Torres V
    Am J Med Sci; 2009 Apr; 337(4):295-6. PubMed ID: 19402208
    [No Abstract]   [Full Text] [Related]  

  • 12. F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma.
    Kunishima S; Taniguchi H; Koh T; Yamaguchi A; Yamagishi H
    Clin Nucl Med; 2001 Sep; 26(9):789-90. PubMed ID: 11507303
    [No Abstract]   [Full Text] [Related]  

  • 13. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    Barker R; Kazmi F; Stebbing J; Ngan S; Chinn R; Nelson M; O'Doherty M; Bower M
    Eur J Nucl Med Mol Imaging; 2009 Apr; 36(4):648-52. PubMed ID: 19050873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
    Xiao L; Zhu HM; Li L
    Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colonic Castleman Disease on FDG PET/CT.
    Li F; Xiao L; Cai H; Li L
    Clin Nucl Med; 2023 Jan; 48(1):71-72. PubMed ID: 35961369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A huge retroperitoneal Castleman's disease - rare entity.
    Jaishanker S; D'Cruze L; Muralidharan S; Gunabooshanam B; Singh KB
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S980-S982. PubMed ID: 38384096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
    Pan Q; Zhang X; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of Castleman disease mimicking a pancreatic tumor.
    Gülmez S; Keklikkıran ZZ; Ölmez T; Barışık NÖ
    Ann Ital Chir; 2019 Dec; 8():. PubMed ID: 31894755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-DOTATATE and 18F-FDG in Castleman Disease.
    Verçosa AFA; Flamini MEDM; Loureiro LVM; Flamini RC
    Clin Nucl Med; 2020 Nov; 45(11):868-870. PubMed ID: 32969902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
    Lee JW; Nam SB; Kim SJ
    Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.